Cargando…

Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies

PURPOSE: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a leading cause of deterioration in patients with otherwise stably controlled COPD. Treatments of AECOPD often require the use of corticosteroid therapy in conjunction with bronchodilators and antibiotics. However, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Raymond, Wang, Yiyang, Ying, Yue, Ding, Mutian, Ouyang, Yunqing, Yuan, Emily, Ye, Daniel, Yuan, Shirley, Li, Guanying, Hou, Winston
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470871/
https://www.ncbi.nlm.nih.gov/pubmed/37651456
http://dx.doi.org/10.1371/journal.pone.0290982
_version_ 1785099777884553216
author Yin, Raymond
Wang, Yiyang
Ying, Yue
Ding, Mutian
Ouyang, Yunqing
Yuan, Emily
Ye, Daniel
Yuan, Shirley
Li, Guanying
Hou, Winston
author_facet Yin, Raymond
Wang, Yiyang
Ying, Yue
Ding, Mutian
Ouyang, Yunqing
Yuan, Emily
Ye, Daniel
Yuan, Shirley
Li, Guanying
Hou, Winston
author_sort Yin, Raymond
collection PubMed
description PURPOSE: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a leading cause of deterioration in patients with otherwise stably controlled COPD. Treatments of AECOPD often require the use of corticosteroid therapy in conjunction with bronchodilators and antibiotics. However, the duration and dosage of corticosteroids still remain unclear. We propose to perform this systematic review and meta-analysis of all available randomized control trials (RCTs) and observational cohort studies to comprehensively assess the efficacy and safety of different corticosteroid duration and dosing regimen in the current body of evidence. METHODS: We will search MEDLINE, EMBASE, CENTRAL via Ovid as well as CINAHL and Web of Science for available literature comparing different corticosteroid duration and dosage in the treatment of AECOPD. We will perform title and full text screening in duplicate, then extract relevant data using a pre-piloted extraction form. We will define short duration as less than 14-day duration of treatment and long duration as greater than 14-day treatment. We will report mortality difference as our primary outcome, with additional comparisons in incidence of re-exacerbation, hospital length of stay, lung function, incidence of hyperglycemia and infection. We will perform risk of bias assessment using the ROB2.0 and ROBINS-I tool, as well as the GRADE assessment to assess the quality of evidence. RESULTS: We will publish the full results of our systematic review and meta-analysis in a peer-reviewed journal. DISCUSSIONS: To our knowledge, this represents an updated and most comprehensive review of the literature comparing different duration and dosing regimen of corticosteroid treatments in AECOPD, as we will include both RCTs and observational studies without date or language restrictions. We aim to validate prior meta-analyses and study findings on the efficacy of short duration corticosteroid therapy over longer treatments and to inform future research directions in dosing regimens.
format Online
Article
Text
id pubmed-10470871
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-104708712023-09-01 Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies Yin, Raymond Wang, Yiyang Ying, Yue Ding, Mutian Ouyang, Yunqing Yuan, Emily Ye, Daniel Yuan, Shirley Li, Guanying Hou, Winston PLoS One Study Protocol PURPOSE: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a leading cause of deterioration in patients with otherwise stably controlled COPD. Treatments of AECOPD often require the use of corticosteroid therapy in conjunction with bronchodilators and antibiotics. However, the duration and dosage of corticosteroids still remain unclear. We propose to perform this systematic review and meta-analysis of all available randomized control trials (RCTs) and observational cohort studies to comprehensively assess the efficacy and safety of different corticosteroid duration and dosing regimen in the current body of evidence. METHODS: We will search MEDLINE, EMBASE, CENTRAL via Ovid as well as CINAHL and Web of Science for available literature comparing different corticosteroid duration and dosage in the treatment of AECOPD. We will perform title and full text screening in duplicate, then extract relevant data using a pre-piloted extraction form. We will define short duration as less than 14-day duration of treatment and long duration as greater than 14-day treatment. We will report mortality difference as our primary outcome, with additional comparisons in incidence of re-exacerbation, hospital length of stay, lung function, incidence of hyperglycemia and infection. We will perform risk of bias assessment using the ROB2.0 and ROBINS-I tool, as well as the GRADE assessment to assess the quality of evidence. RESULTS: We will publish the full results of our systematic review and meta-analysis in a peer-reviewed journal. DISCUSSIONS: To our knowledge, this represents an updated and most comprehensive review of the literature comparing different duration and dosing regimen of corticosteroid treatments in AECOPD, as we will include both RCTs and observational studies without date or language restrictions. We aim to validate prior meta-analyses and study findings on the efficacy of short duration corticosteroid therapy over longer treatments and to inform future research directions in dosing regimens. Public Library of Science 2023-08-31 /pmc/articles/PMC10470871/ /pubmed/37651456 http://dx.doi.org/10.1371/journal.pone.0290982 Text en © 2023 Yin et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Study Protocol
Yin, Raymond
Wang, Yiyang
Ying, Yue
Ding, Mutian
Ouyang, Yunqing
Yuan, Emily
Ye, Daniel
Yuan, Shirley
Li, Guanying
Hou, Winston
Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
title Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
title_full Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
title_fullStr Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
title_full_unstemmed Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
title_short Duration and dosing of systemic corticosteroids for acute exacerbation of COPD, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
title_sort duration and dosing of systemic corticosteroids for acute exacerbation of copd, protocol for a systematic review with meta-analysis of randomized trials and cohort studies
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470871/
https://www.ncbi.nlm.nih.gov/pubmed/37651456
http://dx.doi.org/10.1371/journal.pone.0290982
work_keys_str_mv AT yinraymond durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT wangyiyang durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT yingyue durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT dingmutian durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT ouyangyunqing durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT yuanemily durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT yedaniel durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT yuanshirley durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT liguanying durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies
AT houwinston durationanddosingofsystemiccorticosteroidsforacuteexacerbationofcopdprotocolforasystematicreviewwithmetaanalysisofrandomizedtrialsandcohortstudies